CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3026% above fair value
$74.56+0.84 (+1.14%)
Close on Nov 17, 2026Market cap $3.92BP/E 31.2Yield –
CareDx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
CareDx's revenue for the twelve months ending Sep 30, 2026 was $497.40M, up 38.9% year over year. For fiscal 2025 it was $379.81M, up 13.8% from the year before. Over ten years it grew 29.7% a year on average. The highest annual figure on record is $379.81M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $379.81M | +13.8% |
| FY2024 | Dec 31, 2024 | $333.79M | +19.1% |
| FY2023 | Dec 31, 2023 | $280.32M | -12.9% |
| FY2022 | Dec 31, 2022 | $321.79M | +8.6% |
| FY2021 | Dec 31, 2021 | $296.40M | +54.2% |
| FY2020 | Dec 31, 2020 | $192.19M | +51.3% |
| FY2019 | Dec 31, 2019 | $127.07M | +66.0% |
| FY2018 | Dec 31, 2018 | $76.57M | +58.4% |
| FY2017 | Dec 31, 2017 | $48.32M | +18.9% |
| FY2016 | Dec 31, 2016 | $40.63M | +44.4% |
| FY2015 | Dec 31, 2015 | $28.14M | +3.1% |
| FY2014 | Dec 31, 2014 | $27.31M | +23.6% |
| FY2013 | Dec 31, 2013 | $22.10M | +8.1% |
| FY2012 | Dec 31, 2012 | $20.45M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $139.36M | +39.3% |
| Q2 FY2026 | Jun 30, 2026 | $131.95M | +52.2% |
| Q1 FY2026 | Mar 31, 2026 | $117.70M | +39.0% |
| Q4 FY2025 | Dec 31, 2025 | $108.39M | +25.2% |
| Q3 FY2025 | Sep 30, 2025 | $100.06M | +20.7% |
| Q2 FY2025 | Jun 30, 2025 | $86.68M | -6.1% |
| Q1 FY2025 | Mar 31, 2025 | $84.69M | +17.5% |
| Q4 FY2024 | Dec 31, 2024 | $86.58M | +32.0% |
| Q3 FY2024 | Sep 30, 2024 | $82.88M | +23.4% |
| Q2 FY2024 | Jun 30, 2024 | $92.27M | +31.3% |
| Q1 FY2024 | Mar 31, 2024 | $72.05M | -6.7% |
| Q4 FY2023 | Dec 31, 2023 | $65.57M | -20.4% |
| Q3 FY2023 | Sep 30, 2023 | $67.19M | -15.3% |
| Q2 FY2023 | Jun 30, 2023 | $70.30M | -12.8% |
| Q1 FY2023 | Mar 31, 2023 | $77.26M | -2.7% |
| Q4 FY2022 | Dec 31, 2022 | $82.38M | +4.0% |
| Q3 FY2022 | Sep 30, 2022 | $79.36M | +5.0% |
| Q2 FY2022 | Jun 30, 2022 | $80.63M | +8.7% |
| Q1 FY2022 | Mar 31, 2022 | $79.42M | +17.8% |
| Q4 FY2021 | Dec 31, 2021 | $79.22M | +35.1% |
| Q3 FY2021 | Sep 30, 2021 | $75.59M | +41.6% |
| Q2 FY2021 | Jun 30, 2021 | $74.19M | +77.5% |
| Q1 FY2021 | Mar 31, 2021 | $67.40M | +75.6% |
| Q4 FY2020 | Dec 31, 2020 | $58.64M | +63.7% |
| Q3 FY2020 | Sep 30, 2020 | $53.37M | +57.8% |
| Q2 FY2020 | Jun 30, 2020 | $41.80M | +32.9% |
| Q1 FY2020 | Mar 31, 2020 | $38.38M | +47.7% |
| Q4 FY2019 | Dec 31, 2019 | $35.82M | +52.4% |
| Q3 FY2019 | Sep 30, 2019 | $33.81M | +59.6% |
| Q2 FY2019 | Jun 30, 2019 | $31.45M | +76.5% |
| Q1 FY2019 | Mar 31, 2019 | $25.98M | +84.9% |
| Q4 FY2018 | Dec 31, 2018 | $23.51M | +88.0% |
| Q3 FY2018 | Sep 30, 2018 | $21.18M | +73.8% |
| Q2 FY2018 | Jun 30, 2018 | $17.82M | +48.0% |
| Q1 FY2018 | Mar 31, 2018 | $14.05M | +21.3% |
| Q4 FY2017 | Dec 31, 2017 | $12.50M | +15.1% |
| Q3 FY2017 | Sep 30, 2017 | $12.19M | – |
| Q2 FY2017 | Jun 30, 2017 | $12.05M | – |
| Q1 FY2017 | Mar 31, 2017 | $11.58M | – |
| Q4 FY2016 | Dec 31, 2016 | $10.86M | – |
See a number that looks wrong?